- Category: Products
Products
Coburn releases new HPE-990 lens edger for in-office system use
Latest addition to portfolio of next-gen platforms features four models designed to safely and precisely process specialty lenses, performing step bevels up to 20 mm.Products
Iantrek raises $42M for launch of uveoscleral pathway glaucoma tech
AlloFlo Uveo is a hardware-free, naturally-derived bio-tissue solution for lowering IOP in POAG patients; commercial launch planned for later this year.Products
FDA sends warning letters to three eye drop manufacturers
Agency identifies iVIZIA eye drops, Revitalize Energizing Eye Drops, and FOCUS PI Eye Drops as unapproved new drugs and misbranded products.Products
Beyeonics Vision secures US patent for cataract surgical imaging tech
Patent protection extends to the Beyeonics One, a fully digital HD imaging platform enabling 3D visualization of the surgical field.Products
Clinicians perform first FDA-approved ENCELTO treatment for MacTel
As the first-ever FDA-approved MacTel therapy, ENCELTO (revakinagene taroretcel-lwey) is a single-dose ocular implant administered via an outpatient vitreoretinal surgery.Products
Optomed USA launches next-gen handheld fundus camera
MedTech company’s Optomed Lumo is a portable, non-mydriatic retinal camera designed for “flexibility and ease of use” in a variety of healthcare settingsProducts
FDA approves LENZ Therapeutics' VIZZ for presbyopia
LNZ100, now VIZZ, is the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults.Products
Alcon's TRYPTYR launches to the US market
Company’s first-in-class, prescription-based pharmaceutical features acoltremon, making it the first topical neuromodulator to rapidly increase tear production for DED.Products
Ziemer USA unveils new CTAK module for GALILEI diagnostic platform
Latest addition to the FDA-cleared diagnostic device combines high-resolution corneal tomography with laser-guided stromal inlay preparation for customized corneal reshaping.Products
Olleyes introduces remote ophthalmic tech support for VR-VF testing
Developers of the VisuALL VRP now offer visual field testing with on-demand access to certified ophthalmic professionals across the country.Products
Aetna adds CureSight as medically necessary for amblyopia
Insurance provider is the second in two months to add NovaSight’s digital amblyopia therapy for pediatric patients.Products
Altris AI launches new app for direct OCT syncing
Altris Sync software syncs directly to OCT devices from eight leading manufacturers, enabling automated OCT file uploading and eliminating the need for manual operation.Products
Rain Eye Drops launches dispenser aid for single-use drops
Patent-pending device enables easier administration of vials; available with purchase of CMS 0.5%-formulated RAIN renewal drops for daily dry eye lubrication.Products
Lupin launches Lotemax generic suspension in the US
Loteprednol etabonate ophthalmic suspension, 0.5%, is indicated to treat postoperative inflammation and pain following ocular surgery, among other conditions.Products
Regener-Eyes ends recall of remaining older product inventory
Company previously issued voluntary recall for older bottles in December 2024 following the launch of updated bottles with backflow prevention technology.Products
J&J launches Acuvue Oasys Max 1-Day MF contact lens for astigmatism
Newest addition to the ACUVUE brand is the first and only disposable contact lens for patients with both astigmatism and presbyopia.Products
CSI Dry Eye Software releases update for AI-based clinical platform
Version 6.0 of the cloud-based software features an intuitive dashboard and automated reminders for clinicians diagnosing and treating DED patients.Products
Glenmark launches olopatadine HCl 0.2% to US market
Generic version of Alcon’s Pataday Once Daily Relief eye drops temporarily relieves itchy eyes due to pollen, ragweed, animal hair, and dander.Products
FDA approves Amneal's prednisolone acetate ophthalmic suspension
Referencing Allergan's Pred Forte, this 1% concentrated drop is expected to hit the U.S. market by Q3 2025.Products